-transparent.png){kind=logo}
In the original HL-60 cells (HL-60-S) and an HL-60 subline (HL-60-R) respectively susceptible and resistant to induction of differentiation by retinoic acid or dimethyl sulfoxide, 5-aza-2'-deoxycytidine inhibited growth equally but induced differentiation to a greater extent in HL-60-S. Flow cytometry showed that 5-aza-2'-deoxycytidine produced in both HL-60 lines an increased proportion of cells in G2+M rather than G0/G1 as with retinoic acid. 5-aza-2'-deoxycytidine may have a differentiation-inducing effect in HL-60 provided cells have the competence to differentiate, indicating the importance of an alternate mechanism of action.
Related Publications
A Levva, and
G Schwartsmann, and
L C Boeije, and
H M Pinedo, and
F de Waal
January 1990,
Leukemia research,
A Levva, and
G Schwartsmann, and
L C Boeije, and
H M Pinedo, and
F de Waal
January 1985,
Leukemia research,
A Levva, and
G Schwartsmann, and
L C Boeije, and
H M Pinedo, and
F de Waal
June 1992,
Anti-cancer drugs,
A Levva, and
G Schwartsmann, and
L C Boeije, and
H M Pinedo, and
F de Waal
September 1999,
Cancer letters,
A Levva, and
G Schwartsmann, and
L C Boeije, and
H M Pinedo, and
F de Waal
October 1980,
Cancer letters,
A Levva, and
G Schwartsmann, and
L C Boeije, and
H M Pinedo, and
F de Waal
February 2008,
Biochemical pharmacology,
A Levva, and
G Schwartsmann, and
L C Boeije, and
H M Pinedo, and
F de Waal
June 2014,
Zhongguo shi yan xue ye xue za zhi,
A Levva, and
G Schwartsmann, and
L C Boeije, and
H M Pinedo, and
F de Waal
November 1981,
Journal of the National Cancer Institute,
A Levva, and
G Schwartsmann, and
L C Boeije, and
H M Pinedo, and
F de Waal
July 2003,
Free radical research,
A Levva, and
G Schwartsmann, and
L C Boeije, and
H M Pinedo, and
F de Waal
December 1994,
Blood,
